VYNE Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.63	24.03	19.93	30.67	30.98	42.86
Short-Term Investments	0.3	4.98	41.59	62.63	-	-
Cash & Short-Term Investments	24.93	29.01	61.52	93.31	30.98	42.86
Cash Growth	-50.41%	-52.84%	-34.07%	201.23%	-27.72%	-27.91%
Accounts Receivable	-	-	-	-	-	7.58
Other Receivables	-	-	-	-	5	-
Total Trade Receivables	-	-	-	-	5	7.58
Other Current Assets	0.86	1	2.92	2.66	2.3	12.75
Total Current Assets	25.79	30.01	64.44	95.96	38.28	63.19
Net Property, Plant & Equipment	0.08	0.09	0.21	0.21	-	0.35
Other Long-Term Assets	-	0.06	2.26	1.52	2.48	3.51
Total Assets	25.87	30.16	66.91	97.69	40.76	67.05
Accounts Payable	0.26	1.04	2.71	1.66	2.39	6.51
Accrued Expenses	0.98	1.35	10.7	5.76	6.96	11.55
Current Portion of Leases	-	-	0.1	0.12	-	0.35
Other Current Liabilities	-	-	1.31	-	-	-
Total Current Liabilities	1.24	2.4	14.82	7.54	9.35	18.41
Long-Term Leases	-	-	-	0.1	-	-
Other Long-Term Liabilities	-	-	-	1.31	-	-
Total Long-Term Liabilities	-	-	-	1.41	-	-
Total Liabilities	1.24	2.4	14.82	8.95	9.35	18.41
Common Stock	0	0	0	0	0	0.01
Additional Paid-in Capital	785.87	785.41	783.24	780.04	693.94	688.16
Accumulated Other Comprehensive Income	-	0	0.02	0.03	-	-
Retained Earnings	-	-757.65	-731.17	-691.34	-662.74	-639.53
Total Common Shareholders' Equity	785.88	27.77	52.09	88.74	31.2	48.64
Minority Interest	-	-	-	-	0.21	-
Shareholders' Equity	785.88	27.77	52.09	88.74	31.41	48.64
Total Liabilities & Equity	787.11	30.16	66.91	97.69	40.76	67.05
Total Debt	-	0	0.1	0.21	0	0.35
Net Cash (Debt)	24.93	29.01	61.42	93.09	30.98	42.51
Net Cash Growth	-14.06%	-52.77%	-34.03%	200.54%	-27.13%	72.36%
Net Cash Per Share	0.75	0.87	1.44	9.06	9.72	14.87
Book Value	785.88	27.77	52.09	88.74	31.2	48.64
Book Value Per Share	23.56	0.83	1.22	8.64	9.79	17.01
Tangible Book Value	785.88	27.77	52.09	88.74	31.2	48.64
Tangible Book Value Per Share	23.56	0.83	1.22	8.64	9.79	17.01

Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q